267 related articles for article (PubMed ID: 18188013)
1. Role of matrix metalloproteinases in chronic rhinosinusitis.
Kostamo K; Toskala E; Tervahartiala T; Sorsa T
Curr Opin Allergy Clin Immunol; 2008 Feb; 8(1):21-7. PubMed ID: 18188013
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
3. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis.
Kostamo K; Tervahartiala T; Sorsa T; Richardson M; Toskala E
Laryngoscope; 2007 Apr; 117(4):638-43. PubMed ID: 17429873
[TBL] [Abstract][Full Text] [Related]
4. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
[TBL] [Abstract][Full Text] [Related]
5. Rhinosinusitis in children and asthma severity.
Pawankar R; Zernotti ME
Curr Opin Allergy Clin Immunol; 2009 Apr; 9(2):151-3. PubMed ID: 19307886
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies.
Mastroianni CM; Liuzzi GM
Trends Mol Med; 2007 Nov; 13(11):449-59. PubMed ID: 18029231
[TBL] [Abstract][Full Text] [Related]
7. Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?
MacFadyen RJ
Curr Opin Pharmacol; 2007 Apr; 7(2):171-8. PubMed ID: 17317319
[TBL] [Abstract][Full Text] [Related]
8. Gene-expression signatures of nasal polyps associated with chronic rhinosinusitis and aspirin-sensitive asthma.
Platt M; Metson R; Stankovic K
Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):23-8. PubMed ID: 19532090
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of matrix metalloproteinases and TIMPs.
Nagase H; Visse R; Murphy G
Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
[TBL] [Abstract][Full Text] [Related]
10. What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus?
Tayebjee MH; Lip GY; MacFadyen RJ
Diabet Med; 2005 Dec; 22(12):1628-35. PubMed ID: 16401304
[TBL] [Abstract][Full Text] [Related]
11. Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis.
Keeling J; Herrera GA
Microsc Res Tech; 2008 May; 71(5):371-9. PubMed ID: 18300288
[TBL] [Abstract][Full Text] [Related]
12. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases.
Lagente V; Boichot E
J Mol Cell Cardiol; 2010 Mar; 48(3):440-4. PubMed ID: 19818795
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases in asthma and COPD.
Demedts IK; Brusselle GG; Bracke KR; Vermaelen KY; Pauwels RA
Curr Opin Pharmacol; 2005 Jun; 5(3):257-63. PubMed ID: 15907912
[TBL] [Abstract][Full Text] [Related]
14. Vascular remodeling and protease inhibition--bench to bedside.
Sluijter JP; de Kleijn DP; Pasterkamp G
Cardiovasc Res; 2006 Feb; 69(3):595-603. PubMed ID: 16387286
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
16. Tissue remodeling in chronic rhinosinusitis.
Van Bruaene N; Bachert C
Curr Opin Allergy Clin Immunol; 2011 Feb; 11(1):8-11. PubMed ID: 21150430
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of the role of matrix metalloproteinases and their tissue inhibitors in chronic mitral valvular disease (valvular endocardiosis) in dogs.
Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA
Vet J; 2009 Apr; 180(1):88-94. PubMed ID: 18295518
[TBL] [Abstract][Full Text] [Related]
18. [Metalloproteinases and their inhibitors: the importance of extracellular matrix degradation in malignancy].
Sela B
Harefuah; 2000 Dec; 139(11-12):446-51. PubMed ID: 11341192
[No Abstract] [Full Text] [Related]
19. Regulation of matrix metalloproteinases (MMP)-2/-9 expression in eosinophilic chronic rhinosinusitis--cell culture by interleukin-5 and -13?
Sauter A; Stern-Straeter J; Sodha S; Hörmann K; Naim R
In Vivo; 2008; 22(4):415-21. PubMed ID: 18712166
[TBL] [Abstract][Full Text] [Related]
20. Influence of persistent canine distemper virus infection on expression of RECK, matrix-metalloproteinases and their inhibitors in a canine macrophage/monocytic tumour cell line (DH82).
Puff C; Krudewig C; Imbschweiler I; Baumgärtner W; Alldinger S
Vet J; 2009 Oct; 182(1):100-7. PubMed ID: 18684651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
